sb 203580 has been researched along with arsenic in 5 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (arsenic) | Trials (arsenic) | Recent Studies (post-2010) (arsenic) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 27,806 | 280 | 13,049 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deb, DK; Kalvakolanu, DV; Kambhampati, S; Minucci, S; Mohindru, M; Platanias, LC; Ravandi, F; Sassano, A; Verma, A | 1 |
| Choi, HI; Kim, HJ; Kim, T; Lee, IS; Shim, MJ; Yang, SJ | 1 |
| Li, A; Liu, Q; Wang, X; Ye, J; Zhou, J | 1 |
| Ballon, DJ; Chang, CC; Cheng, HY; Feng, Y; Huang, J; Liu, S; Mo, A; Rice, L; Wen, J; Zu, Y | 1 |
| Hirano, T; Hu, XM; Onda, K; Tanaka, S; Toyoda, H; Yuan, B; Zhou, Q | 1 |
5 other study(ies) available for sb 203580 and arsenic
| Article | Year |
|---|---|
Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to arsenic trioxide.
Topics: Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Bone Marrow Cells; Enzyme Activation; Enzyme Inhibitors; Growth Inhibitors; Humans; Imidazoles; Isoenzymes; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Oxides; p38 Mitogen-Activated Protein Kinases; Pyridines; rac1 GTP-Binding Protein; Tumor Cells, Cultured | 2002 |
Arsenic trioxide induces apoptosis in chronic myelogenous leukemia K562 cells: possible involvement of p38 MAP kinase.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Caspases; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Microscopy, Electron; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Mitogen-Activated Protein Kinases; Oxides; p38 Mitogen-Activated Protein Kinases; Pyridines | 2002 |
Inhibition of mitogen-activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Butadienes; Cell Survival; DNA; Enzyme Inhibitors; Flavonoids; Growth Inhibitors; Humans; Imidazoles; MAP Kinase Kinase 1; Nitriles; Oxides; p38 Mitogen-Activated Protein Kinases; Pyridines; Thymidine; Tissue Culture Techniques; Tumor Cells, Cultured | 2005 |
P38 MAPK inhibition enhancing ATO-induced cytotoxicity against multiple myeloma cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspases; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Humans; Imidazoles; Molecular Chaperones; Multiple Myeloma; Neoplasm Proteins; Oxides; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Tumor Cells, Cultured; Up-Regulation | 2008 |
Involvement of oxidative stress associated with glutathione depletion and p38 mitogen-activated protein kinase activation in arsenic disulfide-induced differentiation in HL-60 cells.
Topics: Apoptosis; Arsenicals; Blotting, Western; CD11b Antigen; Cell Differentiation; Cell Survival; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Flow Cytometry; Glutathione; HL-60 Cells; Humans; Imidazoles; Membrane Potential, Mitochondrial; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pyridines; Reactive Oxygen Species; Sulfides | 2014 |